Bionano Genomics Inc (BNGO)
$1.14
0.03 (2.70%)
BNGO Stock Quote Delayed 30 Minutes
Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics
Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
318.22M
PE Ratio
-0.19
EPS
-6.02
Volume (Avg. Vol.)
869,873
Day's Range
$1.09 - $1.15
52-Week Range
$0.71 - $8.20
Dividend & Yield
N/A (N/A)
BNGO Stock Predictions, Articles, and Bionano Genomics Inc News
BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheering
Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know.
Wait for the Reddit Set to Sell Before Buying Bionano Stock
With the "story" behind it still years in the making, take your time with BNGO stock. At some point, its meme stock investors will cash out, sending it back to more reasonable prices.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on gene-editing stocks like NTLA and on recovering crypto prices.
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
Gene editing stocks are getting a boost on Monday morning after Intellia Therapeutics said it was successful using CRISPR gene-editing therapy directed inside the body to an internal organ.
Don’t Wait Around for a Short Squeeze on Bionano Genomics Stock
A popular trade on social media, BNGO stock has some bullish catalysts. But the primary spark, the short squeeze, might not fire.
Geographic Expansion Enables Healthy Diagnosis for Bionano Genomics
As Bionano's Saphyr system gains international recognition, BNGO stock deserves another chance at breaking through $15 and beyond.
The Owners of Bionano Stock Will Be Hurt by Dilution
BNGO stock looks decent until you dive deeper and understand what's really going on. The shares' outlook isn't good.
Bionano Genomics: Did Reddit Squirrels Find a Nut?
Bionano Genomics offers a system called Saphyr that does optical genetic sequencing. If the technique floods the market, it could be a winner.
Analyst Says Bionano Genomics Has 26% Upside: Should You Buy?
BTIG analyst Sung Ji Nam recently initiated coverage of Bionano Genomics with a buy rating and a price target of $10. Is BNGO stock a buy?    Â
Midday Market Update: The 10 Biggest Gainers Today
Monday's already halfway over and that means it's time for a midday market update with meme stocks rising higher on a rally today.
BNGO Stock: The Big News Lifting Bionano Genomics This Morning
BNGO stock is gaining on Monday thanks to r/WallStreetBets interest and a new corporate higher bringing a wealth of experience.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on a new wave of meme stocks that includes SENS, CLNE and BNGO stock.
BNGO Stock: r/WallStreetBets Is Betting Big on a Short Squeeze for Bionano
Today, amid an overall red day for meme stocks, BNGO stock has soared as speculation begins to build this could be the next short squeeze.
Bionano Stock Is Enticing on Strong Q1 Results and Saphyr’s Progress
Demand for Bionano's Saphyr tool is climbing, while new, potentially life-saving uses are being found for it. BNGO stock remains a buy.
The Bear Case For Bionano Genomics Carries More Weight
Bionano Genomics will have to show how its products are different than the competition if BNGO stock is to hold on to its recent gains.
Bionano Genomics Moves Into Speculative Buy Territory
Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%. Is it a buy?
Bionano Genomics Just Can’t Kick the Cash-Raising Bug With All Its Dilution
Bionano Genomics can't kick the cash-raising bug. BNGO stock could fall to $1.85, its potential cash per share if it continues to raise cash.
